Search clinical trials for: GEP NET

Total 90190 results

Regeneron Pharmaceuticals

Not yet recruiting

A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies

Melanoma | Advanced Solid Tumors | Clear-Cell Renal-Cell Carcinoma (ccRCC)
UNC Lineberger Comprehensive Cancer Center
National Institute on Minority Health and Health Disparities (NIMHD)

Not yet recruiting

Physical Activity Centers Empowerment (PACE)

Colorectal Neoplasms

United States
GlaxoSmithKline

Not yet recruiting

Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Patient-derived Organoids and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)

Lung Cancer, Non-Small Cell

United Kingdom
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Observational Study on GEP-and Pulm-NET Treated at FPG (ETNA-FPG)

Neuroendocrine Tumors | Pulmonary Neuroendocrine Neoplasm | Gep Net

Italy
Complement Theory Inc.

Recruiting

A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Other Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Not yet recruiting

A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources (CONNECT)

Stage IV Lung Cancer | Stage III Lung Cancer | Stage II Lung Cancer
Guy's and St Thomas' NHS Foundation Trust
Pontificia Universidad Catolica de Chile; University of Rotterdam, The Netherlands

Not yet recruiting

UK ANDROMEDA-Shock-2 RCT

Septic Shock
The Central Hospital of Lishui City

Not yet recruiting

Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC

Carcinoma | Small Cell Lung Cancer

China
Xinhua Hospital, Shanghai Jiao Tong University...

Recruiting

PEELED INTERNAL LIMITING MEMBRANE REPOSITION

Macular Holes

China
Fudan University

Not yet recruiting

Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer

Triple-negative Breast Cancer
Bristol-Myers Squibb

Recruiting

Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients

Advanced Renal Cell Carcinoma (aRCC)

United States
Peking Union Medical College Hospital

Not yet recruiting

SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs

Gastro-entero-pancreatic Neuroendocrine Tumor
Merck Sharp & Dohme LLC

Recruiting

A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant, Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004)

Non-small Cell Lung Cancer

United States
National University Hospital, Singapore
National University of Singapore

Recruiting

Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL)

Breast Cancer

Singapore
Merck Sharp & Dohme LLC

Recruiting

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Breast Neoplasms

Israel, United States, Taiwan
Merck Sharp & Dohme LLC
ModernaTX, Inc.

Recruiting

A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004)

Renal Cell Carcinoma

United States, Australia, Canada, Chile, Taiwan
Merck Sharp & Dohme LLC
ModernaTX, Inc.

Recruiting

A Study of Pembrolizumab (MK-3475) Plus V940 in Participants With Bladder Cancer Post-Radical Resection (V940-005)

Bladder Cancer

Canada, Germany, Australia, United States, Poland, Spain, Chile, France, Sweden, Italy
Pfizer

Recruiting

A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Melanoma | Neoplasms | Renal Cell Carcinoma | Non-small-cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Colorectal Carcinoma | Ovarian Carcinoma

Puerto Rico, Japan, United States
Queensland Centre for Gynaecological Cancer
GlaxoSmithKline Research & Development Limited

Not yet recruiting

SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) (SATELLITE)

Mmr Deficiency | Endometrial Cancer Stage I | Immune-related Adverse Event | Endometrioid Endometrial Adenocarcinoma

Australia
Amsterdam UMC, location VUmc

Recruiting

Pulsed Radiofrequency Therapy on Peripheral Nerves Monitoring Pain, Quality of Life, Patient Satisfaction and Efficacy (PURPOSE)

Neuropathic Pain

Netherlands
UMC Utrecht
German Cancer Research Center (DKFZ), Heidelberg, Germany; German Sport University... and other collaborators

Not yet recruiting

Personalized Live-remote Exercise Training for Cancer Survivors (LION)

Neoplasms

Netherlands
Ain Shams University

Recruiting

Effect of PPV+ILM Peeling +/- Subretinal Injection of Ringer Lactate in Management of Nontractional Refractory DME

Efficacy | Safety

Egypt
Sun Yat-sen University

Recruiting

Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer

Breast Cancer | Refractory Breast Carcinoma

China
Lorenzo delSorbo

Not yet recruiting

Prone Positioning in Neurologically Deceased Potential Organ Donors to Improve Donor Lung Function and Lung Transplant Recipient Outcomes (P-POD)

Lung Transplant Failure

Canada
Assistance Publique - Hôpitaux de Paris

Recruiting

Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort (OPERANDI-NET)

Radiotherapy | Gastroenteropancreatic Neuroendocrine Tumor

France
Changping Laboratory
Fujian Maternity and Child Health Hospital; Jining Medical University; Xi'an... and other collaborators

Not yet recruiting

pBFS Guided rTMS Over Cognitive Control Network for ASD

Autism Spectrum Disorder
Ipsen

Not yet recruiting

A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly (BackSOM)

Acromegaly | Gastro-enteropancreatic Neuroendocrine Tumor
Massachusetts General Hospital
National Institute of Neurological Disorders and Stroke (NINDS)

Not yet recruiting

Physiology of Human Brain Connectivity

Healthy
Zhujiang Hospital

Not yet recruiting

Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy

Hepatocellular Carcinoma | Hyperthermic Intraperitoneal Chemotherapy | Ruptured Liver
Sun Yat-sen University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Nasopharyngeal Carcinoma

China
National Cancer Institute (NCI)

Recruiting

Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

Small Cell Carcinoma of the Bladder | High Grade Neuroendocrine Tumors of the Urinary Tract

United States
Abbott Medical Devices

Recruiting

VOLT-AF IDE Clinical Study

Atrial Fibrillation | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Atrial Arrhythmia

United States, Australia, Belgium, Germany, Spain, Netherlands, France, Austria, Canada, Czechia, Italy, United Kingdom
Huabo Biopharm Co., Ltd.

Recruiting

A Study of HB0025 Injection in Patients With Advanced Renal Cancer

Renal Cancer

China
Istituto Ortopedico Rizzoli

Not yet recruiting

Multicentric European Study In Patients With Vertebral Metastases

Spinal Metastases

Netherlands, Germany, Hungary
Sichuan University

Recruiting

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

Lung Cancer | Extensive-stage Small-cell Lung Cancer

China
University of Louisville
National Institute of Mental Health (NIMH)

Recruiting

Innovations in Personalizing Treatment Study (T-NIPT-ED)

Eating Disorders

United States
Sun Yat-sen University

Recruiting

Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors

Keratosis | Eyelid Tumor | Pigmented Nevi | Xanthelasma Palpebrarum

China
Universidad Nacional de Colombia
Fundación Salud de los Andes

Not yet recruiting

Personalized Vaccine for TNBC Immunotherapy (TEBICA003 TNBC)

Breast Cancer Female

Colombia
Children's National Research Institute

Not yet recruiting

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) (IMPACT)

Brain Tumor
Guy's and St Thomas' NHS Foundation Trust

Recruiting

Evaluation of the Implementation of Personalised Follow-up in Head and Neck Cancer (EMPOWER)

Head and Neck Cancer

United Kingdom
Merck Sharp & Dohme LLC

Recruiting

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Non-small Cell Lung Cancer (NSCLC)

China, Australia, United States, Turkey, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand
St. Antonius Hospital
ZonMw: The Netherlands Organisation for Health Research and Development; Pitié-Salpêtrière...

Recruiting

Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation (POP ATLANTIS)

Severe Aortic Valve Stenosis

Netherlands
National Cancer Institute (NCI)

Not yet recruiting

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as Small Cell, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer

Squamous Cell Carcinoma of the Penis | Renal Medullary Carcinoma | Squamous Cell Carcinoma of the Bladder | Small Cell Carcinoma of the Bladder | Small Cell Carcinoma of the Urinary Tract | Squamous Cell Carcinoma of the Urinary Tract | Primary Adenocarcinoma of the Bladder | Primary Adenocarcinoma...

United States
Daiichi Sankyo
Merck Sharp & Dohme LLC

Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Solid Cancer

Japan, China, Taiwan
Fudan University
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Erasmus Medical Center
National Institute for Public Health and the Environment (RIVM); Netherlands...

Recruiting

Shift Work Intervention Strategies for Night Shift Workers (GRIP)

Shift-Work Related Sleep Disturbance

Netherlands
Radboud University Medical Center
KU Leuven; Tel-Aviv Sourasky Medical Center; IRCCS Policlinico S. Matteo

Recruiting

The Effect of Compensation Strategies on Gait Impairment in Parkinson's Disease (UNITE-PD)

Parkinson Disease

Netherlands
National Cancer Institute, Egypt

Not yet recruiting

Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain

Pain | Oropharyngeal Cancer | Pulsed Radiofrequency | Super Voltage Pulsed Radiofrequency | Glossopharyngeal Nerve

Egypt
University of Miami
Varian Medical Systems

Not yet recruiting

The University of Miami Adapt (UAdapt) Trial

Prostate Cancer

United States
Australasian Gastro-Intestinal Trials Group
The University of New South Wales; Walter and Eliza Hall Institute of Medical...

Recruiting

NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer (NEO-IMPACT)

Pancreatic Cancer

Australia

Search clinical trials for: GEP NET

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations